investor call

By Jonah Comstock May 5, 2016
On yesterday’s Q1 earnings call, Fitbit CEO James Park spoke quite a bit about his product’s potential for a wider role in healthcare. He highlighted the device’s popularity among researchers, the recent Dana Farber study, and even the anecdote of the device being used to make a treatment decision about a patient’s atrial fibrillation. But he didn’t stop there. “We are learning that lack of...